Palvella Therapeutics (PVLA) PT Raised to $80 at Stifel
Tweet Send to a Friend
Stifel analyst Samimy Annabel raised the price target on Palvella Therapeutics (NASDAQ: PVLA) to $80.00 (from $60.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
